Quantcast

Latest Clinical pharmacology Stories

2014-07-03 12:39:55

Cleveland Clinic Analysis of clinical trials shows pipeline for therapeutics is small; 99.6 percent of drug attempts fail Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer's disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments. The paper, "Alzheimer's Disease Drug Development...

2014-06-30 23:14:05

This seminar will provide an in-depth snapshot of the key principles and requirements for advertising and promotion expectations and ensuring compliance success by David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry. San Diego, CA (PRWEB) June 30, 2014 The FDA regulates the promotion of prescription drugs, biologics, medical devices and biotechnology products to ensure that the...

2014-06-27 23:10:35

In May 2014, the FDA released a draft guidance that covers the selection and approval process for proposed names of both prescription and nonprescription human drugs and biologics. FDAnews has teamed with drug-naming expert Dr. Susan Proulx to present a 90-minute webinar that will look closely at the draft guidance and its recommended 4-step process. Falls Church, VA (PRWEB) June 27, 2014 Choosing the Right Drug Name: How to Increase Your Chances for Approval **FDAnews Webinar** July...

2014-06-27 23:08:11

Roger Denton of Schlichter, Bogard & Denton, LLP reports that a recent lawsuit alleges that the blood thinning medication Xarelto® is linked to serious and life-threatening bleeding events. St. Louis, MO (PRWEB) June 27, 2014 According to a recent lawsuit filed in the Philadelphia County Court of Common Pleas (Stuntebeck v. Janssen Research & Development LLC et al, Case No.140201754), the anticoagulant drug Xarelto® (rivaroxaban) is alleged to cause serious and...

2014-06-26 23:16:13

On June 20, the FDA announced that all Flexi-Seal CONTROL Fecal Management System Kits are recalled (Class I) by ConvaTec, Inc. as no 510k application was submitted to FDA. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 26, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Flexi-Seal CONTROL Fecal...

2014-06-26 23:02:52

The firm currently represents patients who allege that they have suffered serious side effects from use of Xarelto. Rockville Centre, NY (PRWEB) June 26, 2014 The Rottenstein Law Group LLP, a national personal injury law firm that represents clients with claims stemming from injuries allegedly caused by dangerous prescription drugs, notes an increase in the number of adverse event reports involving the anticoagulant drug Xarelto® over other similarly prescribed drugs. “We are...

2014-06-25 23:16:43

On June 20, the FDA notified that is requiring all approved testosterone products to include a warning in the drug labeling about the risk of venous blood clots. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 25, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Testosterone...

2014-06-24 12:28:52

New Bill Profits California Drugstore Lobby At Patients' Expense WASHINGTON, June 24, 2014 /PRNewswire-USNewswire/ -- Mail-service and specialty pharmacies will save California consumers, employers, unions, and government plans $1.8 billion on prescription drug costs in 2015, according to new research from Visante released by the Pharmaceutical Care Management Association (PCMA). However, these savings are at risk because of new legislation (AB 2418) backed by the California drugstore lobby...

2014-06-20 08:23:33

BUENA, N.J. and HAYWARD, Calif., June 20, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted its seventh abbreviated new drug application (ANDA) in 2014 to the U.S. Food and Drug Administration (FDA). The seventh ANDA submission was in connection with an existing development, supply and marketing agreement with Impax Laboratories, Inc. (NASDAQ: IPXL). The agreement designates IGI...

2014-06-19 23:15:26

OMICS Group cordially invites the participants across the globe to attend the 3rd International Summit on Toxicology & Applied Pharmacology during October 20-22, 2014 in Chicago, USA focussing on the theme: “New Challenges and Innovations in Pharmacological and Toxicological Sciences”. Los Angeles, CA (PRWEB) June 19, 2014 OMICS Group Toxicology Summit is unique in several ways as it is planning to discuss the most innovative and current issues in the diversified fields such as...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related